FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to new derivatives of piperazinylpentamide of the formula (I) which inhibit activity of protease encoded by human immunodeficiency virus. Invention describes also a pharmaceutical composition based on compound of the formula (I) that is used for inhibition of HIV-infection. EFFECT: enhanced effectiveness. 13 cl, 4 tbl, 17 ex
Authors
Dates
1999-06-10—Published
1992-11-03—Filed